Verapamil,a possible repurposed therapeutic candidate for stroke under hyperglycemia  

作　　者：Saifudeen Ismael Tauheed Ishrat 

机构地区：[1]Department of Anatomy and Neurobiology,University of Tennessee Health Science Center,Memphis,TN,USA [2]Pharmaceutical Sciences,Neuroscience Institute,University of Tennessee Health Science Center,Memphis,TN,USA

出　　处：《Neural Regeneration Research》2022年第11期2418-2419,共2页中国神经再生研究（英文版）

基　　金：the National Institute of Health,R01-NS097800 (to TI)。

摘　　要：Admission hyperglycemia is an independent predictor,that contributes to hemorrhagic transformation (HT),and worsened functional outcome following reperfusion therapy with tissue plasminogen activator (tPA) in ischemic stroke.Clinical studies have revealed a strong association between hyperglycemia and incidence of HT independent of prior diabetes diagnosis (Alvarez-Sabin et al.

关 键 词：diagnosis Clinical 

分 类 号：R971[医药卫生—药品]